Creative Medical Technology Takes 80% Control of BioDefense in Cash-and-Stock Purchase

Creative Medical Technology entered into a Stock Purchase Agreement to increase its ownership in BioDefense to 80%. The company acquired 4,000,000 BioDefense shares from Creative Acquisition for $200,000 in cash and 1,000,000 shares of Creative Medical Technology common stock. Following the deal, C…